107 related articles for article (PubMed ID: 9860292)
1. Bendamustine as salvage treatment in patients with advanced progressive breast cancer: a phase II study.
Höffken K; Merkle K; Schönfelder M; Anger G; Brandtner M; Ridwelski K; Seeber S
J Cancer Res Clin Oncol; 1998; 124(11):627-32. PubMed ID: 9860292
[TBL] [Abstract][Full Text] [Related]
2. Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.
Eichbaum MH; Schuetz F; Khbeis T; Lauschner I; Foerster F; Sohn C; Schneeweiss A
Anticancer Drugs; 2007 Sep; 18(8):963-8. PubMed ID: 17667603
[TBL] [Abstract][Full Text] [Related]
3. Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine.
Reichmann U; Bokemeyer C; Wallwiener D; Bamberg M; Huober J
Ann Oncol; 2007 Dec; 18(12):1981-4. PubMed ID: 17872900
[TBL] [Abstract][Full Text] [Related]
4. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas.
Bremer K
J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340
[TBL] [Abstract][Full Text] [Related]
5. Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia.
Kath R; Blumenstengel K; Fricke HJ; Höffken K
J Cancer Res Clin Oncol; 2001 Jan; 127(1):48-54. PubMed ID: 11206271
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer.
Kollmannsberger C; Gerl A; Schleucher N; Beyer J; Kuczyk M; Rick O; Casper J; Sosada M; Rie C; Kanz L; Bokemeyer C
Anticancer Drugs; 2000 Aug; 11(7):535-9. PubMed ID: 11036955
[TBL] [Abstract][Full Text] [Related]
7. Repeated administration of short infusions of bendamustine: a phase I study in patients with advanced progressive solid tumours.
Schöffski P; Hagedorn T; Grünwald V; Paul H; Merkle K; Kowalski R; Ganser A
J Cancer Res Clin Oncol; 2000 Jan; 126(1):41-7. PubMed ID: 10641748
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of bendamustine chemotherapy as second-line treatment in metastatic uveal melanoma.
Schmidt-Hieber M; Schmittel A; Thiel E; Keilholz U
Melanoma Res; 2004 Dec; 14(6):439-42. PubMed ID: 15577312
[TBL] [Abstract][Full Text] [Related]
9. [Primary chemotherapy of metastatic breast carcinoma with bendamustine hydrochloride, methotrexate and fluorouracil versus cyclophosphamide, methotrexate and fluorouracil].
Ruffert K
Zentralbl Chir; 1998; 123 Suppl 5():156-8. PubMed ID: 10063603
[TBL] [Abstract][Full Text] [Related]
10. Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy.
Lissitchkov T; Arnaudov G; Peytchev D; Merkle Kh
J Cancer Res Clin Oncol; 2006 Feb; 132(2):99-104. PubMed ID: 16292542
[TBL] [Abstract][Full Text] [Related]
11. Bendamustine hydrochloride in patients with refractory soft tissue sarcoma: a noncomparative multicenter phase 2 study of the German sarcoma group (AIO-001).
Hartmann JT; Mayer F; Schleicher J; Horger M; Huober J; Meisinger I; Pintoffl J; Käfer G; Kanz L; Grünwald V;
Cancer; 2007 Aug; 110(4):861-6. PubMed ID: 17599772
[TBL] [Abstract][Full Text] [Related]
12. Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO).
Koenigsmann M; Knauf W; Herold M; Pasold R; Müller G; Eschenburg H; Kahl C; Lakner V; Assmann M; Jentsch-Ullrich K; Mohren M; Bartsch R; Franke A
Leuk Lymphoma; 2004 Sep; 45(9):1821-7. PubMed ID: 15223642
[TBL] [Abstract][Full Text] [Related]
13. Weekly administration of bendamustine: a phase I study in patients with advanced progressive solid tumours.
Schöffski P; Seeland G; Engel H; Grünwald V; Paul H; Merkle K; Kowalski R; Ganser A
Ann Oncol; 2000 Jun; 11(6):729-34. PubMed ID: 10942063
[TBL] [Abstract][Full Text] [Related]
14. Bendamustine.
Balfour JA; Goa KL
Drugs; 2001; 61(5):631-8; discussion 639-40. PubMed ID: 11368287
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of bendamustine hydrochloride administered once every 3 weeks in patients with solid tumors.
Rasschaert M; Schrijvers D; Van den Brande J; Dyck J; Bosmans J; Merkle K; Vermorken JB
Anticancer Drugs; 2007 Jun; 18(5):587-95. PubMed ID: 17414628
[TBL] [Abstract][Full Text] [Related]
16. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
Dennie TW; Kolesar JM
Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
[TBL] [Abstract][Full Text] [Related]
17. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
[TBL] [Abstract][Full Text] [Related]
18. Phase II STUdy with 3rd- or 4th-line bendamustine (flat dose) therapy in patients with metastatic breast cancer.
Steinbild S; Frost A; Häring B; Unger C; Mross K
Onkologie; 2009 Sep; 32(8-9):488-92. PubMed ID: 19745592
[TBL] [Abstract][Full Text] [Related]
19. Phase I-II study of bendamustine in patients with acute leukemia and high risk myelodysplastic syndrome.
Chacar C; Jabbour E; Ravandi F; Borthakur G; Kadia T; Estrov Z; Rios MB; Cortes J; Kantarjian H
Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):197-200. PubMed ID: 22578814
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer.
Klippstein A; Schneider CP; Sayer HG; Höffken K
J Cancer Res Clin Oncol; 2003 May; 129(5):316-9. PubMed ID: 12756557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]